Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

NewSelf vs Regenics

NewSelf
Graded #18

Higher grade

vs+21.599999999999994
Regenics
Graded #247

Lower grade

The verdict

NewSelf takes it — 85.6/100 to 64/100.

NewSelf grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueNewSelf +39
93
54
Dose & formulationNewSelf +3
80
77
Clinical oversightNewSelf +10
84
74
Labs & monitoringNewSelf +29
82
53
FulfillmentNewSelf +21
87
66
Contract termsNewSelf +30
85
55
NewSelf · left barRegenics · right bar

The numbers

MetricNewSelfRegenics
WeighScore85.6/10064/100
GradeBC
Scorecard rank#18#247
Semaglutide$100/mo$199/mo (starting dose, compounded)
Tirzepatide$144/mo$279/mo (starting dose, compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
NewSelf

Graded #18 · B

Strengths

  • $100 sema / $144 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

Where it loses points

  • Injection-only
  • Labs/monitoring detail sparse
  • Limited brand history
Regenics

Graded #247 · C

Strengths

  • Hybrid model — in-office visits near Tarzana, CA plus national telemed
  • Physical address published with a Google Maps link
  • Phone support published — uncommon for DTC-only competitors
  • Office hours clearly stated
  • $139/mo first-month intro is competitive with the low end of the market

Where it loses points

  • 503A pharmacy partner not named
  • LegitScript certification not mentioned
  • Full states-served list not disclosed
  • 503A vs 503B designation not specified
  • FDA compounded-medication disclaimer not visible on the homepage

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard